← Back to headlines
AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
Amylyx Pharmaceuticals' stock (AMLX) surged following the successful outcome of a late-stage trial for its GLP-1 drug.
18 Aug, 20:10 — 18 Aug, 20:10
Sources
Showing 1 of 1 sources
Related Stories
US Homeland Security Secretary’s Jet Diverts After Engine Malfunction
42m ago
Good Good Golf Ousts CEO and President Following Controversial Advertising Backlash
53m ago
Elliott Management Takes Stake in Deutsche Telekom to Block T-Mobile Merger
1h ago
Dutch Central Bank Moves 86 Tonnes of Gold from US, Canada to London
1h ago